| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |